Tag: Paragraph IV
Patent Litigation and Generic Entry: Why Disputes Delay Life-Saving Medications
Mar, 23 2026
Patent litigation in the pharmaceutical industry routinely delays generic drug launches by years, keeping prices high and patients without affordable options. The system was designed to balance innovation and competition - but now it mostly protects profits.
Read Article→
online pharmacy
generic drugs
side effects
medication safety
Hatch-Waxman Act
dosage
counterfeit drugs
patent litigation
medication side effects
generic substitution
medication adherence
benefits
pharmacy alternatives
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin
chronic kidney disease